Critical Assessment of Preoperative Urinary Prostate Cancer Antigen 3 on the Accuracy of Prostate Cancer Staging

Critical Assessment of Preoperative Urinary Prostate Cancer Antigen 3 on the Accuracy of Prostate Cancer Staging
复制标题

DOI:
10.1016/j.eururo.2010.10.024
复制
发表时间:
2011-01-01
期刊:
影响因子:
23.4
通讯作者:
Haese, Alexander
Haese, Alexander
中科院分区:
医学1区
文献类型:
--
作者:
Auprich, Marco;Chun, Felix K. -H.;Haese, Alexander

文献摘要

被引文献

相似文献

背景:关于前列腺癌抗原3 (PCA3)评分在根治性前列腺切除术(RP)后更好地识别病理特征的分期意义的认识有限且存在争议。目的:我们的目的是研究PCA3的临床分期意义,以确定RP标本的病理有利和/或不利特征。设计、设置和参与者:来自三个三级转诊中心的连续接受RP的男性的完整回顾性临床和病理数据,包括术前PCA3评分(n = 305)和计算机辅助平面测量肿瘤体积数据(n = 160)。干预:所有患者均接受RP治疗。测量方法:使用PROGENSA法(Gen-Probe, San Diego, CA, USA)评估PCA3评分。除标准危险因素(年龄、直肠指检、前列腺特异性抗原、前列腺体积、活检Gleason评分、阳性核心百分比)外,在logistic回归模型中使用5种不同的PCA3编码来确定5种不同的病理终点:(1)小体积疾病(= 7)。在有和没有PCA3的模型中,使用接收器算子特征分析的曲线下面积(AUC)对每个终点的精度估计进行量化。结果和局限性:PCA3评分在小体积病变和不显著的PCa中显著降低(p
Background: Knowledge about the staging significance of the prostate cancer antigen 3 (PCA3) score to better identify pathologic features after radical prostatectomy (RP) is limited and controversial.Objective: Our aim was to study the clinical staging significance of PCA3 to identify pathologic favorable and/or unfavorable features in the RP specimen.Design, setting, and participants: Complete retrospective clinical and pathologic data of consecutive men who had undergone RP from three tertiary referral centers including preoperative PCA3 scores (n = 305) and computer-assisted planimetrically measured tumor volume data (n = 160) were available.Intervention: All patients were treated with RP.Measurements: PCA3 scores were assessed using the PROGENSA assay (Gen-Probe, San Diego, CA, USA). Beyond standard risk factors (age, digital rectal examination, prostate-specific antigen, prostate volume, biopsy Gleason score, percentage of positive cores), five different PCA3 codings were used in logistic regression models to identify five distinct pathologic end points: (1) low-volume disease (= 7. Accuracy estimates of each end point were quantified using the area under the curve (AUC) of the receiver operator characteristic analysis in models with and without PCA3.Results and limitations: PCA3 scores were significantly lower in low-volume disease and insignificant PCa (p